Lawsuit Overview
An investor in shares of bluebird bio Inc (NASDAQ: BLUE) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by bluebird bio Inc in connection with certain allegedly false and misleading statements made between May 11, 2020 and November 4, 2020. bluebird is a biotechnology company that engages in researchi...
You must register (for free) or login to view the entire case.